Comparing two versions of fluvastatin in healthy adults
Treatments studied
This study tests whether a generic version of the cholesterol-lowering drug fluvastatin works the same as the brand-name version. Healthy volunteers take both versions to compare how the body absorbs them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Weigh at least 50 kg (men) or 45 kg (women) and have a body mass index (BMI) between 19 and 26
- Be generally healthy, with no major heart, liver, kidney, or muscle conditions
- Have no allergies to drugs or foods
- Not smoke more than 5 cigarettes a day, not drink more than 14 alcoholic drinks per week, and avoid recreational drugs
- Stop taking certain medications, supplements, and avoid grapefruit and caffeine during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will compare two versions of a drug (called AD-117 and AD-117A) to see how your body processes them and whether they are safe. You would receive one version and then the other, to compare their effects.
This trial tests a new version of a medicine (AD-228B) against the original (AD-2284) to see how they work in the body and if they are safe. Healthy volunteers are needed.
This trial compares two different forms of a medication to see how they are absorbed and processed by the body and to check that they are safe. It is an early-stage study in healthy volunteers.
This trial compares two versions of an investigational drug to see how they are absorbed and how safe they are in healthy adults. It helps determine if the doses are similar and safe to use.
This trial compares two versions of a medicine (AD-116A and AD-1161) to see if they work the same in the body when taken after eating. It is for healthy adult men to help ensure the new version is as good as the original.
This study compares how two different tablet versions of a combination of vicadrostat and empagliflozin are absorbed by the body. It is for healthy volunteers to see which form works better.
Hear when a new Bioequivalence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.